A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities...
Transcript of A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities...
![Page 1: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/1.jpg)
A Global perspectiveon Heart Failure:
What needs to change?
Martin R Cowie
London, United Kingdom
![Page 2: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/2.jpg)
Global perspective on heart failure: what needs to change?
Martin R CowieProfessor of Cardiology
National Heart & Lung Institute
Imperial College London (Royal Brompton Hospital Campus)
![Page 3: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/3.jpg)
Heart failure: a worldwide burden
1. Ambrosy PA et al. The Global Health and Economic Burden of Hospitalizations for Heart Failure. Lessons Learned From Hospitalized Heart Failure Registries. J Am Coll Cardiol. 2014;63:1123–1133. 2.
Cowie MR et al. Improving care for patients with acute heart failure. 2014. Oxford PharmaGenesis. ISBN 978-1-903539-12-5. Available online at: http://www.oxfordhealthpolicyforum.org/reports/acute-heart-
failure/improving-care-for-patients-with-acute-heart-failure 3. van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey. Eur J Heart Fail.
2014;16:103-111.
26 million
Number of heart failure patients worldwide.1
Health care expenditure attributed to heart failure in Europe and North America.2
1-2%
74% Heart failure patients suffering from at least 1 comorbidity: more likely to worsen the patient’s overall health status.3
![Page 4: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/4.jpg)
Prevalence of HF
www.escardio.org/communities/HFA/Pages/global-heart-failure-awareness-programme.aspx
![Page 5: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/5.jpg)
The cost of heart failure is driven by hospitalisation
British Heart Foundation, 2002 (updated to 2014)
Total cost > GBP 1 billion (1% of annual NHS budget)
(11-13 visits per year)Outpatient investigation 6%
Outpatient care
8%
Drugs
9%
Primary Care
17%
Inpatient care
60%
![Page 6: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/6.jpg)
Number and proportion of HF hospitalisations
www.escardio.org/communities/HFA/Pages/global-heart-failure-awareness-programme.aspx
![Page 7: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/7.jpg)
Heart failure accounts for 1–3% of European hospital admissions
USA (2007)
2.9%
LOS 5.3d
Sweden (2011)
2.2%
LOS 6.4d
Norway (2008)
1.1% Netherlands (2010)
1.5%
Poland (2010)
1.9%
LOS 8d
Austria (2010)
1.0%
LOS 7.3d
Germany (2007)
2.0%
Switzerland
(2011)
1.1%
Spain
(2011)
1.8%
LOS 7.5d
England
(2011–12)
0.4%
LOS 7d
France
(2008)
1.1%
LOS 9.9d
![Page 8: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/8.jpg)
Length of stay for AHF
![Page 9: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/9.jpg)
Trends in HF hospitalisation
www.escardio.org/communities/HFA/Pages/global-heart-failure-awareness-programme.aspx
![Page 10: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/10.jpg)
High hospital readmission rates
www.escardio.org/communities/HFA/Pages/global-heart-failure-awareness-programme.aspx
![Page 11: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/11.jpg)
Co-morbidity is universal
http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Chronic-Conditions/Downloads/2012Chartbook.pdf
![Page 12: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/12.jpg)
http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Chronic-Conditions/Downloads/2012Chartbook.pdf
![Page 13: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/13.jpg)
![Page 14: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/14.jpg)
The runaway train.....?
![Page 15: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/15.jpg)
We will have to do things differently...
![Page 16: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/16.jpg)
National guidance & quality standards
August 2010
Update scheduled
October 2014 June 2011
http://www.nice.org.uk
![Page 17: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/17.jpg)
AHA recommendations for hospital discharge: 2013
Yancy CW et al. Circulation 2013; 128: e240 – 327
![Page 18: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/18.jpg)
ESC 2012 guidance
McMurray et al. Eur Heart J 2012;33:1787–847
Pre-discharge and long-term management
Plan follow-up strategy
Enrol in disease management program, educate, and initiate appropriate lifestyle adjustments
Plan to up-titrate/optimize dose of disease-modifying drugs
Ensure assessed for appropriate device therapy
Prevent early readmission
Improve symptoms, quality of life and survival
![Page 19: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/19.jpg)
What is actually happening?
![Page 20: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/20.jpg)
UK: assessing ‘hospital’ adherence
● Six performance metrics:
● ACEI/ARB on discharge
● Beta-blocker on discharge
● Echo during admission
● Treated on cardiac ward
● Cardiology follow-up
● HF nurse follow-up
Data from 92% of the 150 hospitals
in England & Wales
>40 000 HF admissions per year
60% of total HF admissions
http://www.ucl.ac.uk/nicor/audits/heartfailure/documents/annualreports/hfannual12-13.pdf
![Page 21: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/21.jpg)
Place of Care
Place of care Index admission (%) Readmission (%)
Cardiology ward 50 52
General medical ward 40 37
Other ward 10 11
Place of care Men (%) Women (%)
Cardiology ward 55 44
General medical ward 36 46
Other ward 9 11
Place of care 16-74 (%) ≥75 years (%)
Cardiology ward 65 43
General medical ward 29 46
Other ward 6 11
![Page 22: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/22.jpg)
Specialist Input
http://www.bsh.org.uk/resources/national-heart-failure-audit/
Specialist First admission (%) Readmission (%)
Consultant cardiologist 57 61
Heart failure nurse specialist 22 20
Other consultant with interest in heart failure 6 6
Any HF specialist 78 80
Other clinician 22 20
Input from HF MDT 66 70
![Page 23: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/23.jpg)
Treatment
http://www.bsh.org.uk/resources/national-heart-failure-audit/
Medication
Total prescribed
(%)
ACE inhibitor 73
ARB 18
ACEI and/or ARB 85
Beta blocker 82
MRA 49
ACEI and/or ARB, beta blocker and MRA 39
Loop duiretic 91
Thiazide diuretic 5
Digoxin 22
Treatment on discharge for LVSD
100
90
80
70
60
50
40
30
20
10
0
16-44 45-54 55-64 65-74 75-84 85+
Age Group
% P
res
cri
pti
on
ACEI and/or ARB
Beta
ACEI
Loop diuretic
MRA
ARB
Prescription of secondary prevention medication
by age
![Page 24: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/24.jpg)
Treatment and Specialist Input
http://www.bsh.org.uk/resources/national-heart-failure-audit/
Medication
Seen by any HF
specialist (%) No specialist input (%)
ACE inhibitor 75 62
ARB 18 19
ACEI and/or ARB 87 76
Beta blocker 85 69
MRA 53 32
ACEI and/or ARB, beta blocker and
MRA42 19
Loop diuretic 91 93
Thiazide diuretic 6 3
Digoxin 22 21
Treatment on discharge for LVSD by specialist input
![Page 25: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/25.jpg)
Discharge Planning
http://www.bsh.org.uk/resources/national-heart-failure-audit/
Follow-up appointment Total (%)
Follow-up appointment with MDT scheduled 56
Appointment scheduled within two weeks of discharge 34
0 5 10 15 20+
Ho
sp
itals
Length of stay (median) in days
Median length of stay by hospital
![Page 26: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/26.jpg)
![Page 27: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/27.jpg)
Cardiology follow-up in England....poor!70 000 survivors of HF admission. England, 2009-11.
Bottle A et al. Under review Bottle A et al. In review.
![Page 28: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/28.jpg)
Quality and Outcomes Framework in Primary Care
![Page 29: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/29.jpg)
Not all HF patients receive guideline care in the USA
● Wide variations in hospital performance have been reported
0
20
40
60
80
100
Com
plia
nce (
%)
25th percentile50th percentile75th percentile90th percentile
10th percentile
Discharge
instructions
Smoking
counselling
Medication at
discharge
LV function
assessed
![Page 30: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/30.jpg)
Adherence
![Page 31: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/31.jpg)
Adherence by physiciansMAHLER Study in 6 European countries
Komajda M et al. Eur Heart J 2005; 26: 1653-59.
Adherence = physician following ESC guidelines
for use of ACE inhibitors, β-blockers & spironolactone
NB suppressed zero
![Page 32: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/32.jpg)
Adherence by physiciansMAHLER Study in 6 European countries
Predictors of time to CV hospitalization on multivariable Cox model
Komajda M et al. Eur Heart J 2005; 26: 1653-59.
Factor Hazard Ratio 95% CI P value
NYHA III vs II 1.72 1.29-2.30 0.0002
CHF hosp in past year 1.84 1.38-2.44 <0.0001
Adherence (high vs low) 0.64 0.41-1.00 0.048
Ischaemic aetiology 1.44 1.08-1.91 0.013
Atrial fibrillation 1.34 1.01-1.78 0.045
Diabetes 1.43 1.05-1.93 0.022
Hypertension 0.70 0.53-0.93 0.012
![Page 33: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/33.jpg)
North AmericaCanada
South AmericaEcuador
Eastern EuropeHungary RomaniaBelarus PolandLithuania SlovakiaAustria Russia
Ukraine
AsiaBruneiChinaKoreaMalaysiaThailand
Middle EastBahrain JordanKuwait
KazakhstanOman TurkeyQatar LebanonUAE Egypt
CaucasusArmeniaGeorgiaAzerbaijanAfricaMorocco
Australia
EuropeIreland Germany
Portugal Denmark
Spain GreeceFrance
547 centers in 36 countries
Enrolled between August 2012 and December 2014
![Page 34: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/34.jpg)
Financial Penalties
![Page 35: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/35.jpg)
“Best-practice” based tariff
![Page 36: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/36.jpg)
A community-wide approach is essential
![Page 37: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/37.jpg)
Other approaches?
![Page 38: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/38.jpg)
Policy-makers urged to act
on eight recommendations
Optimize care transitions
Improve patient education
and support
Provide equity of care
for all patients
Appoint experts to lead heart failure across
disciplines
Stimulate research into
new therapies
Develop and implement better measures of care
quality
Improve end-of-life care
Promote acute heart failure prevention
www.oxfordhealthpolicyforum.org
/AHFreport
www.escardio.org/communities/HFA/Pages/
global-heart-failure-awareness-programme.aspx
![Page 39: A Global perspective on Heart Failure: What needs to change?...van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot](https://reader033.fdocuments.us/reader033/viewer/2022052003/601626bd5f0b5e29a90fcc94/html5/thumbnails/39.jpg)
Conclusions
● HF is a global burden
● Policy makers are paying close attention to HF care
● Peformance metrics are increasingly in use
● Rapid access for all patients to timely diagnosis and
treatment is a challenge for ALL healthcare systems
● The age and level of co-morbidity is rising rapidly
● New approaches are needed to face current and future
challenges